A quick look, I couldn't find many studies about this.
This is what Roche says:
PENZBERG, Germany--(BUSINESS WIRE)-- The peroxisome proliferator-activated receptors (PPAR α, β/δ and γ) are nuclear receptors that modulate transcription of regulatory pathways involved in diseases | PENZBERG, Germany--(BUSINESS WIRE)-- The peroxisome proliferator-activated receptors (PPAR α...
www.fiercepharma.com
There are the usual mentions of cancer angiogenesis, somewhere else:
"We show here that pharmacological PPARβ/δ activation increases endothelial cell proliferation in vitro and intensifies tumor angiogenesis in vivo, enhancing tumor progression and metastases formation. Conditional vascular specific overexpression of PPARβ/δ also resulted in enhanced tumor angiogenesis, growth, and metastases formation, suggesting an endothelial cell- specific mechanism for PPARβ/δ function in tumor progression, independent from its contrasting effects on specific tumor cell types.".
One more, that contradicts this, with a bit of abstract below:
Abstract. Ligands for peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) increase skeletal muscle fatty acid catabolism, improve insulin sensitivity,
academic.oup.com
"Contradictory findings are also reported suggesting that PPARβ/δ ligands potentiate tumorigenesis by increasing cell proliferation, by inhibiting apoptosis through phosphorylation of Akt and by increasing cyclooxygenase-2 (COX2) and vascular endothelial growth factor (VEGF) expression. The contradictory findings could be due to differences in the model system (cancer cell line versus in vivo ), differences in cell culture conditions (with and without serum) or differences in ligands. The present study examined the effect of two different PPARβ/δ ligands (GW0742 and GW501516) in human cancer cell lines (HT29, HCT116, LS–174T, HepG2 and HuH7) cultured in the presence or absence of serum and compared in vitro analysis with in vivo analysis. Neither PPARβ/δ ligand increased cell growth or phosphorylation of Akt and no increase in the expression of VEGF or COX2 were detected in any cancer cell line in the presence or absence of serum. Similarly, liver, colon and colon polyps from mice administered these PPARβ/δ ligands in vivo did not exhibit changes in these markers. Results from these studies demonstrate that serum withdrawal and/or differences in ligands do not underlie the disparity in responses reported in the literature. The quantitative nature of the present findings are inconsistent with the hypothesis that cancer cell lines respond differentially as compared with normal cells, and provide further evidence that PPARβ/δ ligands do not potentiate tumorigenesis."
I suppose you are either in the camp that looks at the cancer data and regards it as flawed/irrelevant, or viceversa, so taking cardarine/cardarine+ is a no go (just in case).
Most of the sites I found this referenced in are the ones that are selling it.
I did not look at what Reddit says, since you told me that's where you found out about it.
There was someone saying cardarine plus dose is 10-15mg tops, I forgot where.
You will only be taking it for a few weeks, so you may be thinking that those rat studies are irrelevant for dose+length of administration, for your purposes.
Idk if you have actually taken it, before.
Does the guy coaching you know about this and/or has he had any input in your doping agenda, here?